Background Historically, human monkeypox virus cases in the UK have been limited to imported
infections from west Africa. Currently, the UK and several other countries are reporting a …

We read with interest the article published in this journal by Pezzati et al. on the use of rapid
lateral flow assays to detect antibodies induced by vaccination against SARS-CoV-2 …

Background Health-care workers constitute a high-risk population for acquisition of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Capacity for acute …

Background Access to rapid diagnosis is key to the control and management of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory RT-PCR testing is the …

We read with interest the news that the UK Government has announced deals to procure the
oral antivirals for SARS-CoV-2, molnupiravir (Lagevrio, Merck [Branchburg, NJ, USA]) and …

Background The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
outbreak is a public health emergency and the case fatality rate in the United Kingdom is …

Background Accurately predicting patient outcomes in Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) could aid patient management and allocation of healthcare …

Kidney transplant recipients and other patient groups receiving immunosuppression have a
poor prognosis following presentation with symptomatic severe acute respiratory syndrome …

Background We investigated for change in blood stream infections (BSI) with
Enterobacterales, coagulase negative staphylococci (CoNS), Streptococcus pneumoniae, and …

The Comment by Paul Verweij and colleagues1 on diagnosing COVID-19-associated
pulmonary aspergillosis was insightful and much needed. We note some unanswered questions …